New CARs on and off the road: challenges and new developments in CAR-T cell therapy

被引：3
作者：
Wehrli, Marc [1 ,2 ]
Maus, Marcela, V [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Canc Ctr, Cellular Immunotherapy Program, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
CURRENT OPINION IN PHARMACOLOGY | 2021年 / 59卷
基金：
瑞士国家科学基金会;
关键词：
ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; SAFETY SWITCH; ACTIVATION; DEPLETION; EFFICACY; GENE; MANAGEMENT;
D O I：
10.1016/j.coph.2021.05.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Building on the tremendous success of chimeric antigen receptor T-cell therapy in hematological malignancies, there are efforts under way to overcome the challenges associated with this treatment and expand its application to solid tumors. In this fast-evolving field, new therapeutic options are constantly generated, tested in model systems, and further evaluated in clinical trials. In this review, we provide an overview of recent challenges and developments associated with engineered T cells and chimeric antigen receptor T-cell applications. We report on the most recent progress in hematological malignancies and highlight technical advances for applications in solid tumors.
引用
收藏
页码：116 / 126
页数：11
相关论文
共 72 条
  • [21] Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
    Hoyos, V.
    Savoldo, B.
    Quintarelli, C.
    Mahendravada, A.
    Zhang, M.
    Vera, J.
    Heslop, H. E.
    Rooney, C. M.
    Brenner, M. K.
    Dotti, G.
    [J]. LEUKEMIA, 2010, 24 (06) : 1160 - 1170
  • [22] Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy
    Huarte, Eduardo
    O'Connor, Roddy S.
    Peel, Michael T.
    Nunez-Cruz, Selene
    Leferovich, John
    Juvekar, Ashish
    Yang, Yan-ou
    Truong, Lisa
    Huang, Taisheng
    Naim, Ahmad
    Milone, Michael C.
    Smith, Paul A.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (23) : 6299 - 6309
  • [23] Jacobson CA, 2019, BIOL BLOOD MARROW TR, V25, pS100
  • [24] Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
    Jan, Max
    Scarfo, Irene
    Larson, Rebecca C.
    Walker, Amanda
    Schmidts, Andrea
    Guirguis, Andrew A.
    Gasser, Jessica A.
    Slabicki, Mikolaj
    Bouffard, Amanda A.
    Castano, Ana P.
    Kann, Michael C.
    Cabral, Maria L.
    Tepper, Alexander
    Grinshpun, Daniel E.
    Sperling, Adam S.
    Kyung, Taeyoon
    Sievers, Quinlan L.
    Birnbaum, Michael E.
    Maus, Marcela, V
    Ebert, Benjamin L.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (575)
  • [25] Chimeric Antigen Receptor Therapy
    June, Carl H.
    Sadelain, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 64 - 73
  • [26] Human chimeric antigen receptor macrophages for cancer immunotherapy
    Klichinsky, Michael
    Ruella, Marco
    Shestova, Olga
    Lu, Xueqing Maggie
    Best, Andrew
    Zeeman, Martha
    Schmierer, Maggie
    Gabrusiewicz, Konrad
    Anderson, Nicholas R.
    Petty, Nicholas E.
    Cummins, Katherine D.
    Shen, Feng
    Shan, Xinhe
    Veliz, Kimberly
    Blouch, Kristin
    Yashiro-Ohtani, Yumi
    Kenderian, Saad S.
    Kim, Miriam Y.
    O'Connor, Roddy S.
    Wallace, Stephen R.
    Kozlowski, Miroslaw S.
    Marchione, Dylan M.
    Shestov, Maksim
    Garcia, Benjamin A.
    June, Carl H.
    Gill, Saar
    [J]. NATURE BIOTECHNOLOGY, 2020, 38 (08) : 947 - +
  • [27] Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
    Kloss, Christopher C.
    Lee, Jihyun
    Zhang, Aaron
    Chen, Fang
    Melenhorst, Jan Joseph
    Lacey, Simon F.
    Maus, Marcela V.
    Fraietta, Joseph A.
    Zhao, Yangbing
    June, Carl H.
    [J]. MOLECULAR THERAPY, 2018, 26 (07) : 1855 - 1866
  • [28] Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
    Kloss, Christopher C.
    Condomines, Maud
    Cartellieri, Marc
    Bachmann, Michael
    Sadelain, Michel
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (01) : 71 - +
  • [29] B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
    Kochenderfer, James N.
    Dudley, Mark E.
    Feldman, Steven A.
    Wilson, Wyndham H.
    Spaner, David E.
    Maric, Irina
    Stetler-Stevenson, Maryalice
    Phan, Giao Q.
    Hughes, Marybeth S.
    Sherry, Richard M.
    Yang, James C.
    Kammula, Udai S.
    Devillier, Laura
    Carpenter, Robert
    Nathan, Debbie-Ann N.
    Morgan, Richard A.
    Laurencot, Carolyn
    Rosenberg, Steven A.
    [J]. BLOOD, 2012, 119 (12) : 2709 - 2720
  • [30] Designed protein logic to target cells with precise combinations of surface antigens
    Lajoie, Marc J.
    Boyken, Scott E.
    Salter, Alexander, I
    Bruffey, Jilliane
    Rajan, Anusha
    Langan, Robert A.
    Olshefsky, Audrey
    Muhunthan, Vishaka
    Bick, Matthew J.
    Gewe, Mesfin
    Quijano-Rubio, Alfredo
    Johnson, JayLee
    Lenz, Garreck
    Nguyen, Alisha
    Pun, Suzie
    Correnti, Colin E.
    Riddell, Stanley R.
    Baker, David
    [J]. SCIENCE, 2020, 369 (6511) : 1637 - +
12345678